{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/42334"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/42334","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"The molecular mechanisms of Alzheimer's disease and the promise of novel targeted therapies","abstract":"Alzheimer’s disease is a common cause of dementia in the elderly population that is characterized by progressive neurodegeneration and decline in cognitive functions. Scientists do not yet fully understand the biological mechanisms that cause Alzheimer’s disease, making it increasingly difficult to develop targeted therapies that thoroughly address the responsible agents that lead to dementia and subsequently Alzheimer’s disease. There is currently no cure available to permanently stop the progression of or to reverse the damage due to Alzheimer’s disease. This study aims to provide an overview of the potential causes of Alzheimer’s disease and review the current pharmacological treatment options for addressing the symptoms of Alzheimer’s disease and emerging therapies including immunotherapy and gene therapy.","abstract_html":"Alzheimer’s disease is a common cause of dementia in the elderly population that is characterized by progressive neurodegeneration and decline in cognitive functions. Scientists do not yet fully understand the biological mechanisms that cause Alzheimer’s disease, making it increasingly difficult to develop targeted therapies that thoroughly address the responsible agents that lead to dementia and subsequently Alzheimer’s disease. There is currently no cure available to permanently stop the progression of or to reverse the damage due to Alzheimer’s disease. This study aims to provide an overview of the potential causes of Alzheimer’s disease and review the current pharmacological treatment options for addressing the symptoms of Alzheimer’s disease and emerging therapies including immunotherapy and gene therapy.","abstract_has_math":false,"creators":["Lee, Helen Hyewon"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Offner, Gwynneth","Symes, Karen"],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021","date_published":"2021","updated_at":"2026-11-18T20:15:12Z","subjects":["Biochemistry"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/42334","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/42334","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F42334","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Offner, Gwynneth","Symes, Karen"]},{"key":"dc:creator","label":"Author","values":["Lee, Helen Hyewon"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2021-03-30T13:02:21Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2021-03-30T13:02:21Z"]},{"key":"dc:date.issued","label":"Date","values":["2021"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2021-03-29T22:13:45Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biochemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/42334"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Alzheimer’s disease is a common cause of dementia in the elderly population that is characterized by progressive neurodegeneration and decline in cognitive functions. Scientists do not yet fully understand the biological mechanisms that cause Alzheimer’s disease, making it increasingly difficult to develop targeted therapies that thoroughly address the responsible agents that lead to dementia and subsequently Alzheimer’s disease. There is currently no cure available to permanently stop the progression of or to reverse the damage due to Alzheimer’s disease. This study aims to provide an overview of the potential causes of Alzheimer’s disease and review the current pharmacological treatment options for addressing the symptoms of Alzheimer’s disease and emerging therapies including immunotherapy and gene therapy."]},{"key":"dc:title","label":"Title","values":["The molecular mechanisms of Alzheimer's disease and the promise of novel targeted therapies"]}]}],"canonical_facts":{"dc:contributor.advisor":["Offner, Gwynneth","Symes, Karen"],"dc:creator":["Lee, Helen Hyewon"],"dc:date.accessioned":["2021-03-30T13:02:21Z"],"dc:date.available":["2021-03-30T13:02:21Z"],"dc:date.issued":["2021"],"dc:date.updated":["2021-03-29T22:13:45Z"],"dc:description.abstract":["Alzheimer’s disease is a common cause of dementia in the elderly population that is characterized by progressive neurodegeneration and decline in cognitive functions. Scientists do not yet fully understand the biological mechanisms that cause Alzheimer’s disease, making it increasingly difficult to develop targeted therapies that thoroughly address the responsible agents that lead to dementia and subsequently Alzheimer’s disease. There is currently no cure available to permanently stop the progression of or to reverse the damage due to Alzheimer’s disease. This study aims to provide an overview of the potential causes of Alzheimer’s disease and review the current pharmacological treatment options for addressing the symptoms of Alzheimer’s disease and emerging therapies including immunotherapy and gene therapy."],"dc:identifier.uri":["https://hdl.handle.net/2144/42334"],"dc:language.iso":["en_US"],"dc:subject":["Biochemistry"],"dc:title":["The molecular mechanisms of Alzheimer's disease and the promise of novel targeted therapies"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:15:12Z"}